| Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and … P Prasad, CR Gordijo, AZ Abbasi, A Maeda, A Ip, AM Rauth, RS DaCosta, ... ACS nano 8 (4), 3202-3212, 2014 | 548 | 2014 |
| Classification of cell types using a microfluidic device for mechanical and electrical measurement on single cells J Chen, Y Zheng, Q Tan, E Shojaei-Baghini, YL Zhang, J Li, P Prasad, ... Lab on a Chip 11 (18), 3174-3181, 2011 | 230 | 2011 |
| A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood–brain barrier targeting brain metastases of breast cancer J Li, P Cai, A Shalviri, JT Henderson, C He, WD Foltz, P Prasad, ... ACS nano 8 (10), 9925-9940, 2014 | 157 | 2014 |
| A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor αvβ3 Integrin Receptors Reveals Cyclic RGD as A Double‐Edged Sword AJ Shuhendler, P Prasad, M Leung, AM Rauth, RS DaCosta, XY Wu Advanced healthcare materials 1 (5), 600-608, 2012 | 117 | 2012 |
| Colloidally stable silicon nanocrystals with near‐infrared photoluminescence for biological fluorescence imaging EJ Henderson, AJ Shuhendler, P Prasad, V Baumann, F Maier‐Flaig, ... Small 7 (17), 2507-2516, 2011 | 110 | 2011 |
| pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells A Shalviri, G Raval, P Prasad, C Chan, Q Liu, H Heerklotz, AM Rauth, ... European Journal of Pharmaceutics and Biopharmaceutics 82 (3), 587-597, 2012 | 103 | 2012 |
| Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts P Prasad, A Shuhendler, P Cai, AM Rauth, XY Wu Cancer letters 334 (2), 263-273, 2013 | 100 | 2013 |
| RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells D Shan, J Li, P Cai, P Prasad, F Liu, AM Rauth, XY Wu Drug delivery and translational research 5, 15-26, 2015 | 85 | 2015 |
| Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model AJ Shuhendler, P Prasad, RX Zhang, MA Amini, M Sun, PP Liu, ... Molecular pharmaceutics 11 (8), 2659-2674, 2014 | 72 | 2014 |
| Hybrid Quantum Dot−Fatty Ester Stealth Nanoparticles: Toward Clinically Relevant in Vivo Optical Imaging of Deep Tissue AJ Shuhendler, P Prasad, HKC Chan, CR Gordijo, B Soroushian, ... ACS nano 5 (3), 1958-1966, 2011 | 69 | 2011 |
| Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer AZ Abbasi, P Prasad, P Cai, C He, WD Foltz, MA Amini, CR Gordijo, ... Journal of controlled release 209, 186-196, 2015 | 67 | 2015 |
| Plant-based stearidonic acid as sustainable source of omega-3 fatty acid with functional outcomes on human health P Prasad, P Anjali, RV Sreedhar Critical Reviews in Food Science and Nutrition 61 (10), 1725-1737, 2021 | 63 | 2021 |
| Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice T Zhang, P Prasad, P Cai, C He, D Shan, AM Rauth, XY Wu Acta Pharmacologica Sinica 38 (6), 835-847, 2017 | 58 | 2017 |
| A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells P Prasad, J Cheng, A Shuhendler, AM Rauth, XY Wu Drug delivery and translational research 2, 95-105, 2012 | 46 | 2012 |
| Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation AJ Shuhendler, P Prasad, P Cai, KKW Hui, JT Henderson, AM Rauth, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (6), 795-805, 2013 | 22 | 2013 |
| RGD-conjugated nanoparticles for targeted inhibition of adhesion and migration of integrin αvβ3-overexpressing breast cancer cells. D Shan, P Cai, P Prasad, AM Rauth, XY Wu Cancer Research 73 (8_Supplement), 4339-4339, 2013 | 2 | 2013 |
| A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa … S Verma, H Sabbour, N Alamuddin, F Alawadi, H Alkandari, ... Diabetes, Obesity and Metabolism 25 (6), 1444-1452, 2023 | 1 | 2023 |
| Multifunctional nanoparticle compositions and uses thereof X Wu, CR Gordijo, AZ Abbasi, P Prasad, MA Amini US Patent 11,497,809, 2022 | 1 | 2022 |
| Nanotechnology-Based Strategies To Enhance Chemo-And Radiation Therapy In Breast Cancer P Prasad University of Toronto (Canada), 2014 | 1 | 2014 |
| Awareness and Perceptions Towards Inflammatory Risk in Atherosclerotic Cardiovascular Disease: A Multinational Survey Amongst Cardiologists N Marx, I Komuro, AA Mohseni Zonoozi, P Prasad, J Qian, JF Saraiva, ... Circulation 148 (Suppl_1), A12463-A12463, 2023 | | 2023 |
